erve stimulation for treatment of pain in herpetic infectio
Phase 3
- Conditions
- Health Condition 1: - Health Condition 2: G548- Other nerve root and plexus disorders
- Registration Number
- CTRI/2020/10/028456
- Lead Sponsor
- Department of Anaesthesiology Critical Care JNMCH AMU Aligarh UP India
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
age 18 years to 70 years
Diagnosed case of post herpetic neuralgia
Pain located at cervical, thoracic, lumbar or sacral region
Patient willing to participate in the study
Exclusion Criteria
1.Pregnant patient
2.Diabetic patients
3.Patient having in-dwelling electronic devices
such as pacemaker, cochlear implants or other
implants
4.Patients on anticoagulant therapy
5.Previous trauma in the dermatomal level
affected with post herpetic neuralgia
6.Patients on treatment for vitamin B12
deficiency
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the degree and duration of pain relief in patients of post herpetic neuralgia using NRS(Numerical Rating Scale) <br/ ><br>Timepoint: 1st cycle Baseline, 4 hours <br/ ><br>2nd cycle Preprocedure, 4hours <br/ ><br>3rd cycle Preprocedure, 4hours <br/ ><br>4th cycle Preprocedure, 4hours <br/ ><br>5th cycle Preprocedure, 4hours <br/ ><br>6th cycle Preprocedure, 4hours <br/ ><br> Follow up period <br/ ><br>2nd,4th,6th week
- Secondary Outcome Measures
Name Time Method To evaluate and compare the changes in quality of life (QoL) in the two groups of PHN <br/ ><br>To evaluate and access any complications arising due to the procedure <br/ ><br>Timepoint: 6th week of follow up